AN2 Therapeutics Inc.

NASDAQ: ANTX · Real-Time Price · USD
1.13
0.06 (5.61%)
At close: Aug 18, 2025, 3:59 PM
1.14
1.33%
After-hours: Aug 18, 2025, 07:51 PM EDT

AN2 Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-37.38M -45.35M -51.32M -60.7M -64.66M -66.03M -64.73M -59.68M -54.31M -48.62M -40.96M -36.66M -32.26M -27.15M -21.54M -14M -7.05M -2.05M
Depreciation & Amortization
n/a n/a n/a 414K 414K 435K n/a -1.11M -1.09M -1.09M -652K 40K 20K 1K n/a n/a n/a n/a
Stock-Based Compensation
7.73M 8M 8.34M 8.79M 9.06M 8.73M 8.41M 7.65M 6.71M 6.01M 4.39M 3.35M 2.48M 1.42M 974K 541K 187K 8K
Other Working Capital
-827K -2.94M -3.64M -2.06M -71K 2.6M 5.28M 6.68M 5.97M 2.97M 1.22M -2.14M -2M -1.6M -385K 573K -595K 118K
Other Non-Cash Items
-6.46M -2.63M -3.28M -4.43M -4.34M -3.89M -2.78M -724K -309K 77K 77K -237K 7K 72K 432K 409K 390K 379K
Deferred Income Tax
n/a n/a n/a n/a n/a -21K -21K -21K -41K -39K -40K -40K -20K -1K n/a n/a n/a n/a
Change in Working Capital
605K -2.3M -3M -5.13M -1.32M 1.49M 5.83M 10.02M 7.49M 5.35M 3.72M -1.27M -243K -20K 32K 1.94M 57K 497K
Operating Cash Flow
-35.5M -42.29M -49.26M -61.05M -60.84M -59.28M -53.29M -43.86M -41.55M -38.32M -33.46M -34.82M -30.02M -25.68M -20.48M -11.49M -6.8M -1.54M
Capital Expenditures
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
-68.13M -69.06M -46.75M -42.2M -117.63M -118.17M -132.18M -129.79M -66.99M -106.85M -93.84M -92.39M -81.97M -78.27M -77.27M -61.27M -49.28M n/a
Sales Maturities Of Investments
95M 106.55M 101.34M 104.09M 98.34M 90.29M 88.9M 92.15M 89.49M 81.99M 72.06M 70.81M 55.73M 42.23M 27.25M 5M n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a n/a 7.88K 18.76K 24.82K 22.5K -24.86K 13.94M 20.18M 13.2M -36.05M -50.02M -56.27M -49.28M n/a
Investing Cash Flow
26.87M 37.49M 54.59M 61.89M -19.29M -27.88M -43.28M -37.64M 22.5M -24.86M -21.77M -21.58M -26.25M -36.05M -50.02M -56.27M -49.28M n/a
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -11K -11K -11K -11K n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -1.82M -1.82M -1.82M -1.82M n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a n/a n/a 266K 266K 465K 2.27M 2.01M 2.01M 3.62M 840K 600K 600K -1.2M -230K 10K 10K
Financial Cash Flow
88K 88K 372K 51K 66.09M 85.14M 84.99M 155.68M 89.6M 77.73M 140.72M 69.39M 69.16M 61.98M 78.53M 79.5M 79.74M 79.74M
Net Cash Flow
-8.55M -4.71M 5.7M 888K -14.04M -2.02M -11.57M 3.81M 196K -55.81M 15.12M 12.99M 12.89M 248K 8.03M 11.74M 23.66M 78.2M
Free Cash Flow
-35.5M -42.29M -49.26M -61.05M -60.84M -59.28M -53.29M -43.86M -41.55M -38.32M -33.46M -34.82M -30.02M -25.68M -20.48M -11.49M -6.8M -1.54M